OP Asset Management Ltd acquired a new stake in shares of Ralliant Corporation (NYSE:RAL – Free Report) in the first quarter, HoldingsChannel.com reports. The institutional investor acquired 12,899 shares of the company’s stock, valued at approximately $536,000.
A number of other institutional investors have also recently bought and sold shares of RAL. Allworth Financial LP raised its stake in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period. Rothschild Investment LLC raised its position in shares of Ralliant by 98.1% in the 4th quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock worth $31,000 after buying an additional 303 shares during the period. Keybank National Association OH boosted its holdings in Ralliant by 1.6% in the fourth quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock valued at $1,001,000 after acquiring an additional 305 shares during the last quarter. UMB Bank n.a. increased its stake in Ralliant by 49.6% during the fourth quarter. UMB Bank n.a. now owns 983 shares of the company’s stock worth $50,000 after acquiring an additional 326 shares during the last quarter. Finally, Maryland State Retirement & Pension System increased its stake in Ralliant by 1.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock worth $1,117,000 after acquiring an additional 329 shares during the last quarter.
Analyst Ratings Changes
Several equities analysts have recently weighed in on RAL shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Morgan Stanley increased their target price on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Zacks Research upgraded shares of Ralliant from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Wall Street Zen cut shares of Ralliant from a “buy” rating to a “hold” rating in a research report on Sunday. Finally, Oppenheimer boosted their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $69.00.
Ralliant Trading Up 1.8%
NYSE:RAL opened at $73.72 on Wednesday. The business’s 50-day moving average is $59.20 and its two-hundred day moving average is $51.56. The firm has a market capitalization of $8.25 billion and a PE ratio of -6.74. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $75.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05.
Ralliant (NYSE:RAL – Get Free Report) last issued its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.08. The company had revenue of $534.60 million during the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Research analysts predict that Ralliant Corporation will post 2.64 earnings per share for the current fiscal year.
Ralliant Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, June 8th. Ralliant’s payout ratio is presently -1.83%.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Further Reading
- Five stocks we like better than Ralliant
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
